Tag: Immunology & Inflammation
Conquering sunlight sensitivity: Dersimelagon’s promise in photodermatoses

Two rare genetic dermatological conditions, erythropoietic protoporphyria and X-linked protoporphyria, bring about excruciating pain and skin damage upon exposure to sunlight. In groundbreaking research, a new medication called dersimelagon is addressing these conditions. Led by Dr Kirstine Belongie and her expert team at Mitsubishi Tanabe Pharma America, a clinical trial was conducted to evaluate dersimelagon’s impact on the onset time […]
Read More… from Conquering sunlight sensitivity: Dersimelagon’s promise in photodermatoses